Topiramate-Actavis (Topiramate)

Topiramate-Actavis belongs to a group of medicines known as antiepileptics. Topiramate-Actavis is used for the treatment of various types of seizures in adults and children, aged 2 years and over. It can also be used for the prevention of migraines in adults. Topiramate-Actavis is not used to treat severe migraines that come on suddenly (acute). It prevents seizures and migraines by acting on the nerves and chemicals in the brain

Please refer to the Topiramate-Actavis Consumer Medicine Information. Available at:https://www.medsafe.govt.nz/Consumers/CMI/t/topiramateactavis.pdf

Adverse event reporting

Please ensure any suspected adverse events and other safety information related to Topiramate-Actavis are reported through the appropriate channels, including Medsafe (https://pophealth.my.site.com/carmreportnz/s) and/or Teva’s Medical Information (email: Medinfo.ANZ@tevapharm.com), to support patient safety and continuous quality improvement.

Before prescribing, please review full Data Sheet available at:

https://www.medsafe.govt.nz/profs/Datasheet/t/topiramateactavistab.pdf

References:

1. Topiramate-Actavis Consumer Medicine Information. Available at: https://www.medsafe.govt.nz/Consumers/CMI/t/topiramateactavis.pdf (accessed July 2025).
2. Mother to Baby Fact Sheet. Topiramate. Available at: https://www.ncbi.nlm.nih.gov/books/NBK582991/pdf/Bookshelf_NBK582991.pdf (accessed July 2025).
3. Topiramate Actavis Data Sheet. Available at: https://www.medsafe.govt.nz/profs/Datasheet/t/topiramateactavistab.pdf (accessed July 2025).